155 related articles for article (PubMed ID: 21572396)
1. The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.
Song YH; Shiota M; Kuroiwa K; Naito S; Oda Y
Mod Pathol; 2011 Sep; 24(9):1272-80. PubMed ID: 21572396
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.
Ottaviani S; Brooke GN; O'Hanlon-Brown C; Waxman J; Ali S; Buluwela L
J Mol Endocrinol; 2013 Dec; 51(3):301-12. PubMed ID: 23997240
[TBL] [Abstract][Full Text] [Related]
3. [Glycine-N-methyltransferase and Malignant Diseases of the Prostate].
Heger Z; Eckschlager T; Stiborová M; Adam V
Klin Onkol; 2016; 29(5):331-335. PubMed ID: 27739310
[TBL] [Abstract][Full Text] [Related]
4. The role of sarcosine metabolism in prostate cancer progression.
Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
[TBL] [Abstract][Full Text] [Related]
5. A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization.
DebRoy S; Kramarenko II; Ghose S; Oleinik NV; Krupenko SA; Krupenko NI
PLoS One; 2013; 8(7):e70062. PubMed ID: 23936142
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Huang YC; Lee CM; Chen M; Chung MY; Chang YH; Huang WJ; Ho DM; Pan CC; Wu TT; Yang S; Lin MW; Hsieh JT; Chen YM
Clin Cancer Res; 2007 Mar; 13(5):1412-20. PubMed ID: 17332283
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Methionine Cycle Genes
Chen PM; Tsai CH; Huang CC; Hwang HH; Li JR; Liu CC; Ko HA; Chiang EI
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008908
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.
Yen CH; Lu YC; Li CH; Lee CM; Chen CY; Cheng MY; Huang SF; Chen KF; Cheng AL; Liao LY; Lee YH; Chen YM
Mol Med; 2012 Mar; 18(1):286-96. PubMed ID: 22160218
[TBL] [Abstract][Full Text] [Related]
10. Orphan nuclear receptor nurr1 as a potential novel marker for progression in human prostate cancer.
Wang J; Yang J; Zou Y; Huang GL; He ZW
Asian Pac J Cancer Prev; 2013; 14(3):2023-8. PubMed ID: 23679312
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
13. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
[TBL] [Abstract][Full Text] [Related]
14. Glycine
Hughey CC; Trefts E; Bracy DP; James FD; Donahue EP; Wasserman DH
J Biol Chem; 2018 Jul; 293(30):11944-11954. PubMed ID: 29891549
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.
Chen M; Huang YL; Huang YC; Shui IM; Giovannucci E; Chen YC; Chen YM
PLoS One; 2014; 9(5):e94683. PubMed ID: 24800880
[TBL] [Abstract][Full Text] [Related]
16. Brucine Suppresses Malignant Progression of Prostate Cancer by Decreasing Sarcosine Accumulation via Downregulation of GNMT in the Glycine/sarcosine Metabolic Pathway.
Miao L; Liu Y; Chen W; Gao C; Zhang Y; Wei J; Cao X
Cell Biochem Biophys; 2024 Jun; ():. PubMed ID: 38877335
[TBL] [Abstract][Full Text] [Related]
17. Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation.
Ji Y; Nordgren KK; Chai Y; Hebbring SJ; Jenkins GD; Abo RP; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Chai X; Zhang J; Fridley BL; Yee VC; Wieben ED; Weinshilboum RM
Drug Metab Dispos; 2012 Oct; 40(10):1984-92. PubMed ID: 22807109
[TBL] [Abstract][Full Text] [Related]
18. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.
Huidobro C; Toraño EG; Fernández AF; Urdinguio RG; Rodríguez RM; Ferrero C; Martínez-Camblor P; Boix L; Bruix J; García-Rodríguez JL; Varela-Rey M; Mato JM; Martínez-Chantar ML; Fraga MF
J Mol Med (Berl); 2013 Aug; 91(8):939-50. PubMed ID: 23475283
[TBL] [Abstract][Full Text] [Related]
19. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
